Broker's call: Emami (Buy)

| Updated on December 02, 2020 Published on December 03, 2020

Prabhudas Lilladher

Emami (Buy)

Target: ₹526

CMP: ₹434.85

We are upgrading target price of Emami to ₹526 (₹450 earlier) as we increase PE multiple from 26 to 28x (last 5-year average 38.6x, 25 per cent discount to coverage universe) and rollover valuations to FY23. We believe Emami has hit a sweet spot for growth led by: 1) strong rural demand; 2) strong demand for winter care products on early onset of winter; 3) low base for Q3; 4) Kesh king has gained traction and is gaining share in premium hair oil segment; strong demand for immunity boosters like Chawyanprash and Kesari jeevan; and benign input costs of LLP and Mentha oil.

We believe success of F&H re-launch and pick up in male grooming portfolio is key to sustaining growth beyond next 2/3 quarters. Emami has taken steps for broad based growth with new launches in immunity boosters, health and hygiene products (sanitisers, handwash, anti-septic soaps, floor cleaners, surface cleaners etc.), although we remain cautious on scalability.

We believe worst is over and accelerated amortisation, net cash balance sheet (₹250 crore in Q2-21), 40-50 per cent dividend payout, gradual reduction in promoter pledge (45 per cent, likely to decline in Q4) are positive.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on December 03, 2020
This article is closed for comments.
Please Email the Editor